Literature DB >> 3421582

Lovastatin and rhabdomyolysis.

J Z Ayanian, C S Fuchs, R M Stone.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3421582     DOI: 10.7326/0003-4819-109-8-682

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  17 in total

Review 1.  Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust.

Authors:  M H Davidson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Cytochrome P450 drug interactions within the HMG-CoA reductase inhibitor class: are they clinically relevant?

Authors:  Jennifer Martin; Henry Krum
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Rhabdomyolysis associated with lovastatin and erythromycin use.

Authors:  D H Spach; J E Bauwens; C D Clark; W G Burke
Journal:  West J Med       Date:  1991-02

4.  Myopathic effects of lovastatin.

Authors:  W N Suki
Journal:  West J Med       Date:  1991-02

5.  Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System.

Authors:  Beatrice A Golomb; Abril Verden; Alexis K Messner; Hayley J Koslik; Keith B Hoffman
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

Review 6.  Bezafibrate induced rhabdomyolysis.

Authors:  E Kanterewicz; R Sanmartí; J Riba; I Trias; J Autonell; J Brugués
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

Review 7.  Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors:  David Williams; John Feely
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  More on lovastatin.

Authors:  M A Marinella
Journal:  West J Med       Date:  1995-02

9.  [Severe rhabdomyolysis in a patient receiving lovastatin, danazol, and doxycycline].

Authors:  M Dallaire; M Chamberland
Journal:  CMAJ       Date:  1994-06-15       Impact factor: 8.262

Review 10.  Clinical pharmacokinetics and practical applications of simvastatin.

Authors:  V F Mauro
Journal:  Clin Pharmacokinet       Date:  1993-03       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.